• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一场军备竞赛:先天性抗病毒反应与对抗病毒策略

An arms race: innate antiviral responses and counteracting viral strategies.

作者信息

Schröder M, Bowie A G

机构信息

Viral Immune Evasion Group, School of Biochemistry and Immunology, Trinity College Dublin, Dublin 2, Ireland.

出版信息

Biochem Soc Trans. 2007 Dec;35(Pt 6):1512-4. doi: 10.1042/BST0351512.

DOI:10.1042/BST0351512
PMID:18031256
Abstract

Viral recognition is mediated by different classes of PRRs (pattern-recognition receptors) among which the TLRs (Toll-like receptors) and the RLHs [RIG (retinoic-acid-inducible)-like helicases] play major roles. The detection of PAMPs (pathogen-associated molecular patterns) by these PRRs leads to the initiation of signalling pathways that ultimately result in the activation of transcription factors such as NF-kappaB (nuclear factor kappaB) and IRF-3 [IFN (interferon) regulatory factor-3] and IRF-7 and the induction of pro-inflammatory cytokines and type I IFNs. Viruses have evolved a fine-tuned mechanism to evade detection by the immune system or to interfere with the resulting signalling pathways. Here, we discuss viral evasion proteins that specifically interfere with TLR and/or RLH signalling.

摘要

病毒识别由不同类别的模式识别受体(PRR)介导,其中Toll样受体(TLR)和视黄酸诱导基因I样解旋酶(RLH)发挥主要作用。这些PRR对病原体相关分子模式(PAMP)的检测会引发信号通路的启动,最终导致转录因子如核因子κB(NF-κB)、干扰素调节因子3(IRF-3)和IRF-7的激活,以及促炎细胞因子和I型干扰素的诱导。病毒已经进化出一种精细调节的机制来逃避免疫系统的检测或干扰由此产生的信号通路。在这里,我们讨论特异性干扰TLR和/或RLH信号传导的病毒逃避蛋白。

相似文献

1
An arms race: innate antiviral responses and counteracting viral strategies.一场军备竞赛:先天性抗病毒反应与对抗病毒策略
Biochem Soc Trans. 2007 Dec;35(Pt 6):1512-4. doi: 10.1042/BST0351512.
2
Antiviral signaling through pattern recognition receptors.通过模式识别受体的抗病毒信号传导
J Biochem. 2007 Feb;141(2):137-45. doi: 10.1093/jb/mvm032. Epub 2006 Dec 26.
3
Recognition of viruses by innate immunity.天然免疫对病毒的识别。
Immunol Rev. 2007 Dec;220:214-24. doi: 10.1111/j.1600-065X.2007.00562.x.
4
Toll-like receptor and RIG-I-like receptor signaling.Toll样受体和视黄酸诱导基因I样受体信号通路。
Ann N Y Acad Sci. 2008 Nov;1143:1-20. doi: 10.1196/annals.1443.020.
5
Innate immune responses: crosstalk of signaling and regulation of gene transcription.固有免疫应答:信号转导与基因转录调控的相互作用
Virology. 2006 Aug 15;352(1):14-21. doi: 10.1016/j.virol.2006.04.029. Epub 2006 Jun 6.
6
Viral interference with innate immunity by preventing NF-κB activity.病毒通过阻止 NF-κB 活性来干扰先天免疫。
Cell Microbiol. 2012 Feb;14(2):168-81. doi: 10.1111/j.1462-5822.2011.01720.x. Epub 2011 Nov 23.
7
Recognition of viral nucleic acids in innate immunity.先天免疫中对病毒核酸的识别。
Rev Med Virol. 2010 Jan;20(1):4-22. doi: 10.1002/rmv.633.
8
Toll-like receptors, RIG-I-like RNA helicases and the antiviral innate immune response.Toll样受体、RIG-I样RNA解旋酶与抗病毒天然免疫反应
Immunol Cell Biol. 2007 Aug-Sep;85(6):435-45. doi: 10.1038/sj.icb.7100100. Epub 2007 Jul 31.
9
Activation of host pattern recognition receptors by viruses.病毒激活宿主模式识别受体。
Curr Opin Microbiol. 2010 Aug;13(4):503-7. doi: 10.1016/j.mib.2010.05.007. Epub 2010 Jun 9.
10
Toll-like receptors and innate antiviral immunity.Toll样受体与先天性抗病毒免疫
Tissue Antigens. 2006 Apr;67(4):267-76. doi: 10.1111/j.1399-0039.2006.00583.x.

引用本文的文献

1
Murine norovirus virulence factor 1 (VF1) protein contributes to viral fitness during persistent infection.鼠诺如病毒毒力因子 1(VF1)蛋白有助于病毒在持续感染期间的适应性。
J Gen Virol. 2021 Sep;102(9). doi: 10.1099/jgv.0.001651.
2
Nanobased Platforms for Diagnosis and Treatment of COVID-19: From Benchtop to Bedside.基于纳米的 COVID-19 诊断和治疗平台:从实验台到病床。
ACS Biomater Sci Eng. 2021 Jun 14;7(6):2150-2176. doi: 10.1021/acsbiomaterials.1c00318. Epub 2021 May 12.
3
Repurposed Drugs, Molecular Vaccines, Immune-Modulators, and Nanotherapeutics to Treat and Prevent COVID-19 Associated with SARS-CoV-2, a Deadly Nanovector.
用于治疗和预防与严重急性呼吸综合征冠状病毒2(一种致命的纳米载体)相关的2019冠状病毒病的 repurposed 药物、分子疫苗、免疫调节剂和纳米疗法 。 (注:“repurposed”常见释义为“重新利用的”,这里根据语境灵活翻译为“repurposed药物”,即“已批准药物的新用途药物” )
Adv Ther (Weinh). 2021 Feb;4(2):2000172. doi: 10.1002/adtp.202000172. Epub 2020 Oct 25.
4
Host targeted antiviral (HTA): functional inhibitor compounds of scaffold protein RACK1 inhibit herpes simplex virus proliferation.宿主靶向抗病毒药物(HTA):支架蛋白RACK1的功能性抑制剂化合物可抑制单纯疱疹病毒增殖。
Oncotarget. 2019 May 14;10(35):3209-3226. doi: 10.18632/oncotarget.26907.
5
Plum pox virus capsid protein suppresses plant pathogen-associated molecular pattern (PAMP)-triggered immunity.李痘病毒衣壳蛋白抑制植物病原体相关分子模式(PAMP)触发的免疫反应。
Mol Plant Pathol. 2017 Aug;18(6):878-886. doi: 10.1111/mpp.12447. Epub 2016 Aug 8.
6
Crop immunity against viruses: outcomes and future challenges.作物抗病毒免疫:成果与未来挑战。
Front Plant Sci. 2014 Nov 21;5:660. doi: 10.3389/fpls.2014.00660. eCollection 2014.
7
Viral (hepatitis C virus, hepatitis B virus, HIV) persistence and immune homeostasis.病毒(丙型肝炎病毒、乙型肝炎病毒、人类免疫缺陷病毒)持续性感染与免疫稳态。
Immunology. 2014 Nov;143(3):319-30. doi: 10.1111/imm.12349.
8
Hepatitis C virus NS5A protein modulates IRF-7-mediated interferon-α signaling.丙型肝炎病毒 NS5A 蛋白调节 IRF-7 介导的干扰素-α信号通路。
J Interferon Cytokine Res. 2014 Jan;34(1):16-21. doi: 10.1089/jir.2013.0038. Epub 2013 Aug 20.
9
The SCHOOL of nature: IV. Learning from viruses.自然学派:四、向病毒学习
Self Nonself. 2010 Oct;1(4):282-298. doi: 10.4161/self.1.4.13279.
10
Proteasome-independent degradation of canonical NFkappaB complex components by the NleC protein of pathogenic Escherichia coli.致病性大肠杆菌 NleC 蛋白导致经典 NF-κB 复合物成分的蛋白酶体非依赖性降解。
J Biol Chem. 2011 Feb 18;286(7):5100-7. doi: 10.1074/jbc.M110.172254. Epub 2010 Dec 9.